modelA07DA02

Diagram of A07DA02

Extends from Pharmacokinetic.Models.PK_1C_enteral.

Information

name:Opium
ATC code:A07DA02
route:oral
compartments:1
dosage:100mg
volume of distribution:2.5L
clearance:60ml/min
other parameters in model implementation

Opium is a dried latex obtained from the opium poppy (Papaver somniferum) and contains several alkaloids, chiefly morphine, codeine, and thebaine, known for their narcotic and analgesic properties. Historically, opium was used for pain relief and to treat diarrhea, but its use is now largely obsolete and not approved for modern therapeutic use due to its addictive potential and the availability of safer alternatives.

Pharmacokinetics

There are no published studies reporting pharmacokinetic parameters specific to opium as a whole drug in humans; estimates are based on the pharmacokinetics of its main active alkaloid components, such as morphine, when administered orally.

References

  1. Liu, T, et al., & Ivaturi, V (2016). Mechanistic Population Pharmacokinetics of Morphine in Neonates With Abstinence Syndrome After Oral Administration of Diluted Tincture of Opium. Journal of clinical pharmacology 56(8) 1009–1018. DOI:10.1002/jcph.696 PUBMED:https://pubmed.ncbi.nlm.nih.gov/26712409

  2. Berthold, EC, et al., & McCurdy, CR (2022). The Lack of Contribution of 7-Hydroxymitragynine to the Antinociceptive Effects of Mitragynine in Mice: A Pharmacokinetic and Pharmacodynamic Study. Drug metabolism and disposition: the biological fate of chemicals 50(2) 158–167. DOI:10.1124/dmd.121.000640 PUBMED:https://pubmed.ncbi.nlm.nih.gov/34759012

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.TransferRateka (from PK_1C_enteral)0.016666666666666666first order absorption rate
Modelica.Units.SI.TimeTlag (from PK_1C_enteral)600delay between oral administration and absorption (default 10min)

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)